Report overview
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.
This report aims to provide a comprehensive presentation of the global market for Adipose Tissue-derived Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Tissue-derived Stem Cell Therapy. This report contains market size and forecasts of Adipose Tissue-derived Stem Cell Therapy in global, including the following market information:
Global Adipose Tissue-derived Stem Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Adipose Tissue-derived Stem Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Stem Cells Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adipose Tissue-derived Stem Cell Therapy include AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast and Pluristem Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adipose Tissue-derived Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adipose Tissue-derived Stem Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Autologous Stem Cells
Allogeneic Stem Cells
Global Adipose Tissue-derived Stem Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Therapeutic Application
Research Application
Global Adipose Tissue-derived Stem Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adipose Tissue-derived Stem Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adipose Tissue-derived Stem Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adipose Tissue-derived Stem Cell Therapy, market overview.
Chapter 2: Global Adipose Tissue-derived Stem Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Adipose Tissue-derived Stem Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adipose Tissue-derived Stem Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
